AVITA Medical, Inc. (RCEL) Earnings History
Net Loss33 years of earnings data (1993–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
AVITA Medical, Inc. (RCEL) Earnings Overview
As of June 22, 2026, AVITA Medical, Inc. (RCEL) reported trailing twelve-month net income of -$45M, reflecting +27.2% year-over-year growth. The company earned $-0.15 per diluted share over the past four quarters, with a net profit margin of -67.8%.
Looking at the long-term picture, RCEL's historical earnings data spans multiple years. The company achieved its highest annual net income of $184,419 in fiscal 1996.
AVITA Medical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including XTNT ($2M net income, 3.7% margin), TELA (-$40M net income, -48.4% margin), MDXG ($31M net income, 11.6% margin), RCEL has room to improve margins relative to the peer group. Compare RCEL vs XTNT →
RCEL Earnings vs Peers
Earnings metrics vs comparable public companies
RCEL Historical Earnings Data (1993–2025)
33 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$49M | +21.4% | -$42M | $-1.74 | -67.8% | -58.6% |
| 2024 | -$62M | -74.8% | -$57M | $-2.39 | -96.3% | -88.1% |
| 2023 | -$35M | -32.7% | -$43M | $-1.40 | -70.6% | -85.1% |
| 2022 | -$27M | -6.1% | -$28M | $-1.07 | -77.5% | -79.9% |
| 2021 | -$25M | +5.4% | -$25M | $-1.03 | -76.1% | -76.1% |
| 2020 | -$27M | +36.8% | -$27M | $-1.17 | -90.9% | -90.8% |
| 2019 | -$42M | -67.4% | -$43M | $-3.00 | -294.7% | -299.2% |
| 2018 | -$25M | -45.9% | -$26M | $-1.12 | -458.6% | -466.4% |
| 2017 | -$17M | -49.5% | -$19M | $-1.85 | -1370.8% | -1489.9% |
| 2016 | -$12M | -12.1% | -$13M | $-1.72 | -975.0% | -1073.2% |
| 2015 | -$10M | -30.6% | -$11M | $-2.06 | -1025.1% | -1133.1% |
| 2014 | -$8M | -52.8% | -$9M | $-2.23 | -798.1% | -887.0% |
| 2013 | -$5M | +36.4% | -$7M | $-1.58 | -191.8% | -254.2% |
| 2012 | -$8M | -6.6% | -$9M | $-2.69 | -287.5% | -306.7% |
| 2011 | -$8M | -263.8% | -$6M | $-3.19 | -226.4% | -184.7% |
| 2010 | -$2M | +58.3% | -$4M | $-1.53 | -62.5% | -131.3% |
| 2009 | -$5M | -20.9% | -$3M | $-3.93 | -217.9% | -113.0% |
| 2008 | -$4M | +64.5% | -$4M | $-3.75 | -174.9% | -171.5% |
| 2007 | -$12M | +8.7% | -$4M | $-16.51 | -968.8% | -362.9% |
| 2006 | -$13M | -43.8% | -$5M | $-3.24 | -1615.4% | -574.4% |
| 2005 | -$9M | -24.8% | -$9M | $-3.43 | -1005.8% | -1040.6% |
| 2004 | -$7M | -42.9% | -$8M | $-0.18 | -988.6% | -1084.7% |
| 2003 | -$5M | -222.8% | -$5M | $-3.14 | -1281.1% | -1278.5% |
| 2002 | -$2M | -37.7% | -$2M | $-1.92 | -794.8% | -832.3% |
| 2001 | -$1M | +27.0% | -$1M | $-0.56 | - | - |
| 2000 | -$2M | -89.2% | $498,375 | $-0.80 | - | - |
| 1999 | $-812,059 | -44.3% | $-235,702 | $-1.32 | - | - |
| 1998 | $-562,846 | +75.4% | $2M | $-2.25 | -96.5% | 258.4% |
| 1997 | -$2M | -1341.5% | $-97,159 | $-48.58 | - | - |
| 1996 | $184,419 | +114.3% | $-138,814 | $-0.74 | - | - |
| 1995 | -$1M | +33.7% | $-126,546 | $-27.28 | - | - |
| 1994 | -$2M | -759.1% | $-278,478 | $-42.11 | - | - |
| 1993 | $-225,539 | - | $-207,930 | $-5.06 | - | - |
Download Data
Export RCEL earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
33+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
RCEL — Frequently Asked Questions
Quick answers to the most common questions about buying RCEL stock.
What is RCEL earnings per share (EPS)?
RCEL trailing twelve-month (TTM) diluted EPS is $-0.15, reflecting +27.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1993 to 2025 is available in the table on this page.
What is AVITA Medical, Inc.'s net income?
AVITA Medical, Inc. (RCEL) trailing twelve-month net income is $-45M as of 2025. Earnings grew +27.2% year-over-year.
Is RCEL profitable?
RCEL is not currently profitable on a TTM basis, reporting a net loss of $-45M. Net margin is -67.8%. Investors should monitor for a return to profitability.
What is RCEL's earnings growth rate?
RCEL compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1993 to 2025.
What are RCEL's profit margins?
AVITA Medical, Inc. net profit margin is -67.8%, operating margin is -58.6%, and gross margin is +82.1%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is RCEL growing earnings?
Yes, RCEL earnings are accelerating — EPS growth of +27.2% exceeds the 5-year CAGR of N/A. TTM net income reached $-45M. Earnings momentum is strengthening.
What was RCEL's best earnings year?
AVITA Medical, Inc.'s highest annual net income on record is $184419.00, achieved in fiscal year 1996. Earnings history on this page spans 1993 to 2025 and includes all annual and quarterly figures.
What were RCEL's earnings last quarter?
RCEL's most recent reported quarter was Q1 2026. Net income was $-11M with diluted EPS of $-0.35. For a full breakdown of all quarters, see the quarterly earnings table on this page.